This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Sun Pharma Q3 Profit Rises 16%
Business Earnings Report

Sun Pharma Q3 Profit Rises 16%

Analysis based on 7 articles · First reported Feb 01, 2026 · Last updated Feb 01, 2026

Sentiment
40
Attention
2
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The positive earnings report from Sun Pharma led to a significant increase in its stock price on both the BSE and NSE, indicating strong investor confidence in the company's performance. This event is likely to have a positive, albeit localized, impact on the pharmaceutical sector in India.

Pharmaceuticals
Event Summary

Sun Pharma announced a 16% increase in its consolidated net profit for the third quarter ended December 31, 2025, reaching Rs 3,369 crore, up from Rs 2,903 crore in the prior year. Total revenue from operations also rose to Rs 15,520 crore from Rs 13,675 crore. The company's board approved an interim dividend of Rs 11 per equity share. Kirti Ganorkar, MD of Sun Pharma, attributed the growth to strong performance across all businesses, particularly in India, emerging markets, and global innovative medicines. Following the announcement, shares of Sun Pharma climbed nearly 4% on the BSE and NSE.

Key Actions
90 Sun Pharma posted increased consolidated net profit and revenue
85 Sun Pharma stock price increased BSE SENSEX
85 Sun Pharma stock price increased NIFTY 50
70 Sun Pharma approved interim dividend of Rs 11 per equity share
Entities Involved
stock
Sun Pharma
Sun Pharma reported a 16% increase in consolidated net profit and a rise in total revenue for the third quarter, leading to a positive market reaction with its shares climbing.
Importance 100 Sentiment 60
per
Kirti Ganorkar
Kirti Ganorkar, MD of Sun Pharma, commented on the company's well-rounded growth across all businesses, highlighting the success of branded businesses in India, emerging markets, and global innovative medicines.
Importance 20 Sentiment 30
cnt
India
Sun Pharma' branded businesses in India contributed to its well-rounded growth, indicating a strong domestic market performance.
Importance 15 Sentiment 20
index
BSE SENSEX
Sun Pharma shares climbed on the BSE, indicating a positive movement for the stock within the broader market.
Importance 10 Sentiment 10
index
NIFTY 50
Sun Pharma shares advanced on the NSE, reflecting a positive performance for the stock within the Indian market.
Importance 10 Sentiment 10
Relationships
Kirti Ganorkar related ↔ Sun Pharma
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.